Bliss GVS Pharma Limited (BOM:506197)

Bliss GVS Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	1,956	237.94	231.4	249.55	219.15	126.35
Short-Term Investments	50.05	1,176	1,167	384.44	1,130	490.29
Trading Asset Securities	-	-	5.57	49.6	-	-
Cash & Short-Term Investments	2,006	1,413	1,404	683.59	1,349	616.64
Cash Growth	-8.74%	0.70%	105.34%	-49.34%	118.83%	55.25%
Accounts Receivable	4,911	4,384	4,043	3,852	3,928	4,638
Other Receivables	-	120.06	134.02	57.8	119.38	170.47
Receivables	4,911	4,504	4,178	3,910	4,048	4,810
Inventory	1,190	1,257	1,184	1,031	1,239	989.27
Prepaid Expenses	-	24.7	27.76	24.21	31.9	14.32
Other Current Assets	793.64	1,066	1,315	1,325	1,100	1,222
Total Current Assets	8,901	8,265	8,109	6,974	7,769	7,652
Property, Plant & Equipment	4,228	4,177	3,694	3,729	2,948	2,278
Long-Term Investments	460.41	310.67	80.2	568.59	36.75	620.13
Goodwill	77.11	77.11	77.11	77.11	77.11	77.11
Other Intangible Assets	2.28	2.3	1.07	2.29	3.83	5.79
Long-Term Deferred Tax Assets	49.01	-	-	33.33	-	-
Other Long-Term Assets	282.93	176.06	154.99	184.42	252.93	134.35
Total Assets	14,001	13,008	12,116	11,569	11,087	10,768
Accounts Payable	948.99	714.18	609.65	863.9	926.06	742.25
Accrued Expenses	30.16	96.8	64.46	55.09	47.86	50.93
Short-Term Debt	-	232.16	324.17	460.14	607.03	650.38
Current Portion of Long-Term Debt	229.54	279.13	197.98	113.63	210.32	211.11
Current Portion of Leases	46.94	44.1	27.55	11.14	9.42	13.18
Current Income Taxes Payable	204.83	37.74	18.66	26.56	66.49	86.01
Current Unearned Revenue	-	45.7	69.24	34.7	90.08	157.91
Other Current Liabilities	536.16	267.36	262.36	367.44	373.6	124.59
Total Current Liabilities	1,997	1,717	1,574	1,933	2,331	2,036
Long-Term Debt	130.41	198.46	355.92	406.9	232.22	326.04
Long-Term Leases	118.02	127.19	92.79	27.17	34.92	18.29
Long-Term Unearned Revenue	0.4	0.47	0.61	0.74	0.87	1.01
Pension & Post-Retirement Benefits	20.99	43.64	26.74	26.89	10.74	24.98
Long-Term Deferred Tax Liabilities	-	3	35.93	-	13.23	82.09
Other Long-Term Liabilities	52.32	-	-	-	-	-
Total Liabilities	2,319	2,090	2,086	2,394	2,623	2,489
Common Stock	105.65	105.37	104.69	104.15	103.68	103.15
Additional Paid-In Capital	-	404.24	331.64	269.94	212.77	147.57
Retained Earnings	-	10,120	9,324	8,603	7,941	7,826
Comprehensive Income & Other	11,218	-126.06	-88.46	-138.53	-70.73	5.38
Total Common Equity	11,323	10,504	9,672	8,839	8,187	8,083
Minority Interest	358.83	414.71	357.9	335.27	277.6	196.56
Shareholders' Equity	11,682	10,918	10,030	9,174	8,465	8,279
Total Liabilities & Equity	14,001	13,008	12,116	11,569	11,087	10,768
Total Debt	524.91	881.04	998.4	1,019	1,094	1,219
Net Cash (Debt)	1,481	532.41	405.27	-335.39	255.5	-602.36
Net Cash Growth	17.88%	31.37%	-	-	-	-
Net Cash Per Share	13.95	5.02	3.82	-3.18	2.43	-5.71
Filing Date Shares Outstanding	105.62	105.37	104.69	104.15	103.68	103.36
Total Common Shares Outstanding	105.62	105.37	104.69	104.15	103.68	103.15
Working Capital	6,904	6,548	6,535	5,041	5,438	5,616
Book Value Per Share	107.21	99.68	92.39	84.87	78.97	78.36
Tangible Book Value	11,244	10,424	9,594	8,760	8,106	8,000
Tangible Book Value Per Share	106.46	98.93	91.64	84.10	78.19	77.56
Land	-	422.36	409.88	419.83	420.09	144.14
Buildings	-	1,360	1,369	1,437	1,059	1,055
Machinery	-	3,152	2,616	2,580	1,809	1,490
Construction In Progress	-	207.11	78.27	28.01	221.55	23.95

Source: S&P Global Market Intelligence. Standard template. Financial Sources.